newsfilter
← Latest News
Business Wire·

AVROBIO Announces the Appointment of Sean O'Bryan as Chief Regulatory Officer

AVROBIO, Inc. (NASDAQ:AVRO), a leading clinical-stage gene therapy company with a shared purpose to free people from a lifetime of genetic disease, today announced the appointment of Sean O'Bryan as chief regulatory officer. Sean brings a wealth of expe